Local Flu Cases Behind Last Year’s Pace

San Diego, California - Even though fewer flu cases are being reported this season compared to last, the County Health and Human Services Agency is reminding San Diegans to get vaccinated to avoid getting sick.

Potential Tuberculosis Exposure at Lucky Lady Casino

San Diego, California - People who were at the Lucky Lady Casino on weekends between Feb. 23, 2018 and Sept. 30 may have been exposed to tuberculosis, the San Diego County Health and Human Services Agency announced.

Now is the Time to Get a Flu Shot

San Diego, California - Influenza cases are reported year-round. But the typical flu season starts at the end of October and could last until April or May of the following year.

Mary’s Harvest Fresh Foods, Inc. Recalls Wrap and Salad Meat Products due to Possible Salmonella and Listeria Monocytogenes Contamination

Portland, Oregon - Mary’s Harvest Fresh Foods, Inc., a Portland, Ore. establishment, is recalling approximately 916 pounds of ready-to-eat wrap and salad products that contain a corn ingredient that may be contaminated with Salmonella and Listeria monocytogenes, the U.S. Department of Agriculture’s Food Safety and Inspection Service (FSIS) announced Wednesday.

Genomic analysis offers insight into 2018 Nigeria Lassa fever outbreak

Washington, DC - A surge in Lassa fever cases in Nigeria in 2018 does not appear to be linked to a single virus strain or increased human-to-human transmission, according to a genomic analysis published in The New England Journal of Medicine. Multiple institutions collaborated on the report, including the African Center of Excellence for Genomics of Infectious Diseases at Redeemer’s University in Ede, Nigeria; the Broad Institute of MIT and Harvard in Cambridge, Massachusetts; the Scripps Research Institute in La Jolla, California; and Tulane University in New Orleans, among others.

Scientists develop novel vaccine for Lassa fever and rabies

Washington, DC - A novel vaccine designed to protect people from both Lassa fever and rabies showed promise in preclinical testing, according to new research published in Nature Communications. The investigational vaccine, called LASSARAB, was developed and tested by scientists at Thomas Jefferson University in Philadelphia; the University of Minho in Braga, Portugal; the University of California, San Diego; and the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.